0001209191-23-058576.txt : 20231213
0001209191-23-058576.hdr.sgml : 20231213
20231213213424
ACCESSION NUMBER: 0001209191-23-058576
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231213
DATE AS OF CHANGE: 20231213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mackaness James H
CENTRAL INDEX KEY: 0001422484
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36593
FILM NUMBER: 231485419
MAIL ADDRESS:
STREET 1: 1212 TERRA BELLA AVENUE
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLENO THERAPEUTICS INC
CENTRAL INDEX KEY: 0001484565
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 770523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 203 REDWOOD SHORES PARKWAY
STREET 2: SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-213-8444
MAIL ADDRESS:
STREET 1: 203 REDWOOD SHORES PARKWAY
STREET 2: SUITE 500
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
FORMER COMPANY:
FORMER CONFORMED NAME: Capnia, Inc.
DATE OF NAME CHANGE: 20100219
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-11
0
0001484565
SOLENO THERAPEUTICS INC
SLNO
0001422484
Mackaness James H
203 REDWOOD SHORES PKWY, STE 500
REDWOOD CITY
CA
94065
0
1
0
0
Chief Financial Officer
0
Common Stock
2023-12-11
4
M
0
15000
2.595
A
44610
D
Common Stock
2023-12-11
4
S
0
6252
35.4872
D
38358
D
Common Stock
2023-12-11
4
S
0
12381
36.1567
D
25977
D
Common Stock
2023-12-11
4
S
0
13849
37.0645
D
12128
D
Employee stock option (right to buy)
2.595
2023-12-11
4
M
0
15000
0.00
D
2032-07-27
Common Stock
15000
5000
D
The 1-for-15 reverse stock split of the Issuer's Common Stock, effected August 26, 2022, was reflected in a Form 4 filed by the Reporting Person on October 14, 2023. The number of shares reported as beneficially owned following the reported transaction has been reduced by two shares to reflect share rounding as a result of such stock split.
This transaction was executed in multiple trades at prices ranging from $34.83 to $35.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $35.83 to $36.76. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
This transaction was executed in multiple trades at prices ranging from $36.84 to $37.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
The option, originally for 20,000 shares, vested as to one fourth of the shares on August 1, 2022 and each three-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.
/s/ James Mackaness
2023-12-13